LIMN Liminatus Pharma, Inc. Class A Common Stock

100

NASDAQ | Common Stock

Price: $24.22

Decreased by -1.54%
Dollar volume (20D): 2.60 M
ADR%: 27.16

Shares float: 0.00
Shares short: 0.00 [N/A%]
Shares outstanding: 0.00

Market cap: N/A
Beta: N/A
Price/earnings: N/A

20D range: 4.40 24.88
50D range: 4.40 24.88
200D range: 4.40 24.88

Liminatus Pharma, Inc. operates as a clinical-stage immuno-oncology company that develops novel cancer therapies.

The company is based in LA Palma, California.

Quarterly earnings
Annual earnings

Reported date	EPSChange YoY	EstimateSurprise

Quarterly financials
Annual financials

Fiscal ending date	RevenueChange YoY	IncomeChange YoY	ProfitChange YoY